SNORA62: SNORA62 is a small nucleolar RNA (snoRNA) that has been studied in relation to prostate cancer. It is one of the inferred genes that lacks affirmative evidence of its association with prostate cancer [PMC2718658]. In a gene expression analysis, SNORA62 was found in the turquoise module along with two other long non-coding RNAs (lncRNAs), TP53TG1 and RPPH1 [PMC8116958]. Additionally, SNORA62 and SNORA64 were found to be differentially expressed in two age comparisons, suggesting that their expression levels change with age [PMC3636386]. SNORA62 is the sponge orthologue of the human SNORA62 (E2) [PMC4515611]. It has been observed that part of the RPSA intron 4, which contains SNORA62, is present in the RPSAP8 and RPSAP9 pseudogenes [PMC2850357]. In studies on sno/scaRNA profiles in leukemia, dysregulated snoRNAs including SNORD109A, SNORD64, SNORD107, SNORD116-18, SNORA31, SNORA6, and SNORA62 have been identified. Some of these dysregulated snoRNAs have been associated with shorter progression-free survival for chronic lymphocytic leukemia patients [PMC8975097]. The potential modulation of apoptotic effects by SNORA62 on its host genes may offer new strategies for targeting FAU [PMC4515611].